Milestone Pharmaceuticals Inc. ( NASDAQ:MIST ) is possibly approaching a major achievement in its business, so we would... - PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or inhalation. A nasal COVID-19 vaccine, developed using technology from Washington ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

A sprayable body oil from Hume Supernatural. After trying countless lotions, the Dry Body Oil Spray delivered moisturized, ...

From cleaning essentials to beauty supplies, store aisles are packed with brands competing for your loyalty. Making sense of all the labels and product features can be a challenge, that is, without ...

USA, the nation's largest consumer-voted awards program dedicated to recognizing product innovation, has announced the ...

The Mist are officially on a winning streak. Despite an 0-4 start to the inaugural Unrivaled season, they improved to 2-4 with their second straight victory on Monday. They prevailed in a 64-61 ...

Set a few decades after Ender Lilies (but which you don't need to have played to appreciate this standalone adventure), Ender Magnolia: Bloom in the Mist begins in a very similar fashion.

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for bumetanide nasal spray (RSQ-777) for the treatment of edema associated with congestive heart failure, ...

Stewart scored the game-winning free throw in the Mist’s 64-61 win — after a technical foul call on Phantom coach Adam Harrington — in the first of two games on Monday night. “I don’t ...